Immuno Cure Successfully Admitted into the HKSTP Elite Programme
- Written by Reporters
Remarkable funding support for becoming a biotech unicorn
HONG KONG SAR - Media OutReach Newswire - 26 June 2024 - Immuno Cure BioTech ("Immuno Cure") is delighted to announce its recent successful admission to the prestigious Elite Programme of Hong Kong Science & Technology Park ("HKSTP"), positioning the company for accelerated growth and...Read more: Immuno Cure Successfully Admitted into the HKSTP Elite Programme

